About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Baltimore | 548 Studies

Clinical Trials Breast CancerBaltimore

Breast Cancer Clinical Trials in Baltimore

Find 548 clinical trials for breast cancer near Baltimore, Maryland. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Baltimore

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 548 trials

CompletedA Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerThis study is looking at whether Metformin, an agent that is commonly used to treat diabetes, can decrease or affect the ability of breast cancer cells to grow and whether…NCT01101438·Anchorage, Alaska and 343 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

UnknownStudy of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 SignalingThis is a prospective, single arm, open label, multicenter interventional study designed to evaluate the efficacy of neoadjuvant chemotherapy with anti-HER2 antibodies in patients…NCT03412643·Colton, California and 42 others

CompletedDS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]This study will compare DS 8201a to standard treatment. Participants must have HER2 breast cancer that has been treated before.NCT03523585·Chandler, Arizona and 226 others

Active not recruitingA Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial CancerThe reason for this study is to see if the study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or…NCT04188548·Gilbert, Arizona and 73 others

CompletedChemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2Randomized phase II trial to study the effectiveness of chemotherapy with paclitaxel and the monoclonal antibody trastuzumab followed by chemotherapy in treating women who have…NCT00003992·Palo Alto, California and 44 others

TerminatedNeoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast CancerRATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00080626·Baltimore, Maryland

RecruitingPhase IIIb Study of Ribociclib + ET in Early Breast CancerThe purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant…NCT05827081·Birmingham, Alabama and 228 others

CompletedPanobinostat and Letrozole in Treating Patients With Metastatic Breast CancerRATIONALE: Panobinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Estrogen can cause the growth of breast cancer cells.NCT01105312·Scottsdale, Arizona and 171 others

CompletedPhase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer PatientsThis will be a multi-center, prospective, randomized, single-blinded, placebo-controlled phase II trial of trastuzumab + nelipepimut-S/GM-CSF versus trastuzumab + GM-CSF alone.NCT02297698·Santa Monica, California and 23 others

RecruitingTesting the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerThis phase II trial studies how well nab-paclitaxel, durvalumab, and tremelimumab with or without personalized synthetic long peptide vaccine (neoantigen vaccine) works in…NCT03606967·Orange, California and 29 others

TerminatedRO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By SurgeryThis phase I trial studies the side effects and best dose of RO4929097 (gamma-secretase/Notch signalling pathway inhibitor RO4929097) when given together with vismodegib in…NCT01071564·Baltimore, Maryland and 2 others

CompletedA Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid TumorsAn open-label, dose-escalation (Part 1), dose-expansion (Part 2) study to assess the safety, pharmacokinetics (PK), and preliminary efficacy of ABBV-155 alone and in combination…NCT03595059·Birmingham, Alabama and 39 others

RecruitingCirculating Tumor DNAThis is a single-arm, phase II study examining elacestrant in the adjuvant treatment of patients with ER+ breast cancer who test positive for circulating tumor DNA (ctDNA) during…NCT06923527·New Haven, Connecticut and 6 others

UnknownSame-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast ReconstructionThis novel study will assess the feasibility and outcomes of same-day discharge following mastectomy with implant-based pre-pectoral reconstruction.NCT04596683·Washington D.C., District of Columbia and 2 others

CompletedPRS-343 in HER2-Positive Solid TumorsA multi center, open-label, Phase 1 dose escalation study with expansion cohort is designed to determine the MTD, RP2D and dosing schedule of PRS-343 in patients with HER2+…NCT03330561·Tucson, Arizona and 9 others

CompletedAzacitidine and Entinostat in Treating Patients With Advanced Breast CancerThis phase II trial studies how well giving azacitidine and entinostat work in treating patients with advanced breast cancer.NCT01349959·Duarte, California and 6 others

Active not recruitingVeliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney DysfunctionThis phase I trial studies the side effects and the best dose of veliparib when given together with paclitaxel and carboplatin in treating patients with solid tumors that are…NCT01366144·Duarte, California and 16 others

CompletedCognition in the Study of Tamoxifen and RaloxifeneThe purpose of this study is to assess the effects of tamoxifen and raloxifene on cognitive aging in selected cognitively-healthy women.NCT00687102·Phoenix, Arizona and 133 others

TerminatedDecision Support for Women With Breast CancerBreast cancer is a common malignancy among women in the United States. There are a variety of treatment decisions that need to be made.NCT01447771·Baltimore, Maryland

TerminatedMM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer PatientsThis study is an open label, randomized, multicenter trial of MM-302 plus trastuzumab.NCT02213744·Glendale, Arizona and 108 others

PreviousPage 7 of 28Next

Other Conditions in Baltimore

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma